BRAF and rhabdomyosarcoma: To this end, the rhabdomyosarcoma RD cells were treated for 24 hours with 10 μM of the B-RAF inhibitor PLX-4720 and hERG cell membrane protein abundance was analysed by biotinylation of the cell surface proteins with subsequent western blotting and by flow cytometry experiments.